Our Products

Evidence & Literature

Services:

• Targeted literature reviews
• Landscape assessments
• HTA report evaluation

Value Communication

Services:

• AMCP dossiers
• Global value dossiers
• Value propositions

Health Economics

Services:

• Cost-effectiveness analyses (CEAs)
• Budget impact models (BIMs)
• Cost calculators

Real-World Evidence

Services:

• Real-world studies design
• Claims database analysis
• Observational research

AI-Powered Solutions

Services:

• Automated data extraction
• Competitive intelligence tools
• Custom dashboards

Market Access Strategy

Services:

• Global pricing strategy
• Payer advisory boards
• Launch planning

Emerging Biotechs

Early-stage companies developing innovative therapies need strategic guidance on evidence generation and access planning from the start. Our years of experience help them foresee upcoming challenges and requirements, enabling better-informed tradeoff decisions related to their clinical development programs, integrated evidence generation plans, and HEOR strategies. We partner with emerging biotechs to build a solid foundation for future market access success.

Mid-Stage Biopharma

Growing companies preparing for commercialization benefit from our expertise in HTA submissions, payer engagement, and launch readiness. We leverage our proven HEOR playbook to help ensure they meet all requirements for payers and global HTA bodies. From developing comprehensive evidence dossiers to executing multi-market submission strategies, we guide mid-stage biopharma through every step of the market access journey.

Established Pharmaceutical

Mature organizations have substantial resources but face unique challenges in optimizing processes and staying ahead of the curve. While we provide the same strategic HEOR and market access expertise, we also take a different approach by running AI pilot programs to help them integrate cutting-edge technology into their existing workflows. Our innovation engine helps established pharma companies modernize their evidence generation capabilities and achieve operational excellence.